Section 32

Type

Venture Capital

Status

Active

Location

Sillicon Valley, United States

Total investments

121

Average round size

66M

Portfolio companies

81

Rounds per year

17.29

Lead investments

11

Follow on index

0.33

Exits

6

Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareHealth DiagnosticsGeneticsMedicalTherapeutics

Summary

In 2017 was created Section 32, which is appeared as VC. The leading representative office of defined VC is situated in the San Diego. The company was established in North America in United States.

Among the most popular portfolio startups of the fund, we may highlight Coinbase, Auris Health, Inc., Lime. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Software, Medical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Section 32, startups are often financed by Founders Fund, Polaris Partners, Lux Capital. The meaningful sponsors for the fund in investment in the same round are Andreessen Horowitz, Verily, GV. In the next rounds fund is usually obtained by Andreessen Horowitz, GV, Y Combinator.

The fund was created by Bill Maris. We also calculated 2 valuable employees in our database.

Opposing the other organizations, this Section 32 works on 20 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. When the investment is from Section 32 the average startup value is 500 millions - 1 billion dollars. The fund is generally included in 7-12 deals every year. The top activity for fund was in 2019. Considering the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistAI/Big DataB2B/EnterpriseCloud/InfrastructureConsumer/Retail Show 6 more
Stage focus
Seed
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 525000000
Fund raised date
2023-10-05

Analytics

Total investments
121
Lead investments
11
Exits
6
Rounds per year
17.29
Follow on index
0.33
Investments by industry
  • Health Care (58)
  • Biotechnology (54)
  • Artificial Intelligence (23)
  • Medical (19)
  • Therapeutics (19)
  • Show 86 more
Investments by region
  • United States (106)
  • Canada (2)
  • United Kingdom (2)
  • Argentina (2)
  • Netherlands (1)
  • Show 2 more
Peak activity year
2021
Number of Unicorns
3
Number of Decacorns
3
Number of Minotaurs
5

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
186M
Group Appearance index
0.97
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Brightside Health 26 Mar 2024 Internet, Information Technology, Finance, Health Care Late Stage Venture 33M United States, California, San Francisco
Function Oncology 12 Apr 2023 Biotechnology, Genetics, Therapeutics Early Stage Venture 28M United States, California, San Diego
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.